Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
Migdal Insurance & Financial Holdings Ltd., an Israeli company, filed an Amendment No. 1 to a Schedule 13G reporting its beneficial ownership in Ormat Technologies, Inc. common stock. Migdal and its majority- or wholly-owned subsidiaries report beneficial ownership of 3,681,980.51 Ormat ordinary shares, representing 5.99% of the class, based on 61,451,752 ordinary shares outstanding as of July 8, 2026. These shares are held through investment vehicles including Migdal Sal Domestic Equities and Migdal Mutual Funds Ltd., with 3,681,980.51 shares subject to shared voting and shared dispositive power and no sole voting or dispositive power. The filing explains that the securities are largely held for the benefit of insurance policyholders, pension and provident fund members, portfolio clients, and mutual fund unit holders, and that Migdal and its subsidiaries disclaim beneficial ownership beyond their actual pecuniary interest and reject any admission that they form a group for Section 13(d) purposes.
Ormat Technologies executive Willis Aron John reported routine equity compensation activity. On June 30, 2026, 1,812 restricted stock units vested, converting into the same number of Ormat common shares as part of a three-year vesting schedule. Each RSU delivers one share upon vesting.
On July 1, 2026, 451 of these common shares were sold in open-market transactions at an average price of $106.64 per share to satisfy the reporting person’s tax withholding obligations related to the vesting. Following these transactions, he directly holds 1,361 shares of Ormat common stock.
Angel Isaac reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. reported that director Angel Isaac received a grant of 1,245 Restricted Stock Units (RSUs) on June 2, 2026. Each RSU represents the right to receive one share of Ormat common stock when it vests.
The entire RSU grant is scheduled to vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this grant, Isaac holds 1,245 RSUs directly. This is a compensation-related equity award, not an open‑market share purchase or sale.
STERN STANLEY reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Stanley Stern reported a compensation-related grant of 899 Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of Ormat common stock upon vesting, so this award aligns his incentives with shareholders through future equity.
The RSU grant was made on June 2, 2026 and will vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this transaction, Stern’s reported derivative holdings from this grant total 899 RSUs, with no open‑market purchases or sales disclosed in this filing.
Wong Byron G. reported acquisition or exercise transactions in this Form 4 filing.
Ormat Technologies director Byron G. Wong reported an equity award of 899 restricted stock units (RSUs). These RSUs were granted as compensation and carry no purchase price. Each RSU represents the right to receive one share of Ormat common stock upon vesting.
The filing states that this block of 899 RSUs will vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this grant, Wong holds 899 RSUs directly, highlighting a modest, routine alignment of his compensation with future company performance.
SHARIR DAFNA reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Dafna Sharir received a grant of 899 Restricted Stock Units (RSUs) on June 2, 2026. Each RSU represents the right to receive one share of Ormat common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and the filing shows 899 derivative units held following the award.
Barniv Ravit reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Ravit Barniv received a grant of 899 Restricted Stock Units, each representing one share of ORA common stock upon vesting. The entire RSU award is scheduled to vest 100% on June 2, 2027, one year after the grant date.
Marom Michal reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Michal Marom received a grant of 899 Restricted Stock Units on June 2, 2026. Each RSU represents one share of ORA common stock upon vesting. This entire RSU grant is scheduled to vest 100% on June 2, 2027, and Marom now holds 899 RSUs directly.
Corfee Karin reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Karin Corfee received a grant of 899 Restricted Stock Units as equity compensation. Each RSU represents the right to receive one share of ORA common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and Corfee now holds 899 RSUs following the award.
Granot David reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director David Granot reported a new equity compensation award. He received a grant of 899 Restricted Stock Units, each representing the right to receive one share of Ormat common stock upon vesting. These RSUs vest 100% on June 2, 2027, which is the one-year anniversary of the grant date. Following this grant, Granot holds 899 RSUs directly, and the filing does not report any open-market stock purchases or sales, only this compensation-related award.